GlassScriptPhysician profile
Maria A Vegas
NPI 1982813861
$2,118.07
in general payments reported to CMS, 2019-2025
17 companies · $577 in 2025
The $577 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2021: $90.10 · 2022: $464 · 2023: $548 · 2024: $313 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $819.89 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $507.44 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.54 | 2022-2025 | Jardiance |
| Leo Pharma INC. | $108.20 | 2025 | Anzupgo |
| Glaxosmithkline, LLC. | $85.25 | 2022-2023 | Shingrix, Arexvy |
| Lilly USA, LLC | $71.18 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $55.73 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $46.67 | 2023 | |
| Smith+Nephew, INC. | $43.59 | 2025 | Collagenase Santyl |
| Phadia US INC. | $42.88 | 2023-2024 | Immunocap |
| Abbvie INC. | $39.64 | 2021 | |
| Amgen INC. | $39.47 | 2023 | Repatha, Otezla |
| Novo Nordisk INC | $35.94 | 2019-2025 | Rybelsus, Ozempic |
| Phathom Pharmaceuticals, INC. | $24.86 | 2025 | Voquezna |
| Boston Scientific Corporation | $23.81 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.71 | 2024 | |
| Organogenesis INC. | $14.27 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Vegas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.